Ipamorelin Therapy
Support Natural Growth Hormone Release
Ipamorelin therapy at AlphaCare is a medically supervised peptide program designed to stimulate your body’s natural growth hormone production. Rather than replacing hormones, Ipamorelin works with your physiology to support recovery, sleep quality, metabolism, and vitality.
What Is Ipamorelin?
Ipamorelin is a peptide medication that encourages your body to release its own growth hormone (GH) in a more natural, physiologic way. Unlike direct growth hormone injections, Ipamorelin does not replace hormones. Instead, it supports your body’s existing signaling pathways, which may result in improved tolerability and fewer risks when appropriately supervised. Growth hormone plays an important role in sleep quality, tissue repair, muscle recovery, metabolism, and overall vitality.
Our structured peptide program includes:
- Starting dose: 100 mcg nightly
- Possible increase to 200 mcg nightly
- Maximum typical dose: 300 mcg nightly
Treatment courses generally last 8–16 weeks. Therapy is continued only if benefit is observed.
Your provider may consider Ipamorelin if you experience:
- Poor or non-restorative sleep
- Slow recovery from exercise
- Decreased energy or stamina
- Difficulty maintaining lean muscle mass with age
- General decline in vitality despite healthy habits
Ipamorelin is typically discussed after lifestyle factors such as sleep, nutrition, and exercise have been optimized.
Response varies by individual. Potential improvements may include better sleep depth and quality, feeling more rested upon waking, improved recovery after activity, and gradual improvements in energy and body composition. Sleep-related benefits may appear within weeks, while other changes often take longer.
How Is Ispamorelin Taken?
- Injections are typically given in the evening
- Injection sites include the abdomen or thigh
- Sites should be rotated to avoid irritation
- Injection training will be provided by AlphaCare staff
Possible Side Effects
Ipamorelin is generally well tolerated. Possible side effects may include mild redness at the injection site, headache, lightheadedness, nausea, or flushing. Serious side effects are uncommon when used as directed.
Why Choose AlphaCare for CJC-1295 Therapy
CJC-1295 is not FDA-approved, and long-term outcome data are limited. While research shows it can increase growth hormone and IGF-1 levels, most studies are short-term. AlphaCare uses a conservative, evidence-informed approach—offering treatment only after medical evaluation, with goal-directed, time-limited protocols and close monitoring to prioritize safety.
Safety, Monitoring, and Medical Oversight
Your AlphaCare provider will guide you throughout treatment. Therapy may be adjusted or discontinued if there is no meaningful improvement after 8–12 weeks, if side effects outweigh the benefits, or if your health goals change. Regular follow-up is essential to ensure safe and appropriate treatment.
When to Contact AlphaCare
Contact AlphaCare if you experience worsening symptoms, persistent or concerning side effects, injection site reactions that do not improve, or no improvement by your scheduled follow-up. Seek urgent medical care for severe symptoms such as chest pain, shortness of breath, or neurologic changes.